TY - JOUR
T1 - A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection
AU - Baba, Takayuki
AU - Bhutto, Imran A.
AU - Merges, Carol
AU - Grebe, Rhonda
AU - Emmert, David
AU - McLeod, D. Scott
AU - Armstrong, Donald
AU - Lutty, Gerard A.
N1 - Funding Information:
Supported by National Institutes of Health (grants R01-016151 to G.A.L. and EY-01765 to Wilmer) and by the Altsheler-Durell Foundation. T.B. was a Bausch and Lomb Japan Vitreoretinal Research Fellow, an Uehara Memorial Foundation Research Fellow, and a Japan Society for the Promotion of Science Postdoctoral Fellow for Research Abroad. G.A.L. received a Research to Prevent Blindness Senior Scientific Investigator Award in 2008.
PY - 2010/6
Y1 - 2010/6
N2 - The purpose of this study was to develop and characterize a rat model of choroidal neovascularization (CNV) as occurs in age-related macular degeneration. The lipid hydroperoxide 13(S)-hydroperoxy-9Z,11E-octadecadienoic acid (HpODE) is found in submacular Bruch's membrane in aged humans and has been reported to generate neovascularization in a rabbit model. Three weeks after a single subretinal injection of 30 μg of HpODE, eyes of Sprague-Dawley rats were harvested. Follow-up fluorescein angiography was done on other animals until 5 weeks postinjection. Histological studies, immunohistochemical staining, and flatmount choroids for CNV measurements were performed. In addition, we used murine neuronal, bovine endothelial, and human ARPE19 cells for testing the in vitro effects of HpODE. CNV developed in 85.7% of HpODE-injected eyes. The neovascular areas were significantly greater in HpODE-injected eyes compared with those in control eyes (P = 0.023). The CNV had maximum dye leakage at 3 weeks, which subsided by the 5th week. Histologically, CNV extended from the choriocapillaris into the subretinal space. ED1-positive macrophages were recruited to the site. In vitro assays demonstrated that only 30 ng/ml HpODE induced cell proliferation and migration of endothelial cells. HpODE-induced CNV was highly reproducible, and its natural course seems to be ideal for evaluating therapeutic modalities. Because HpODE has been isolated from aged humans, the HpODE-induced rat model seems to be a relevant experimental model for CNV in age-related macular degeneration.
AB - The purpose of this study was to develop and characterize a rat model of choroidal neovascularization (CNV) as occurs in age-related macular degeneration. The lipid hydroperoxide 13(S)-hydroperoxy-9Z,11E-octadecadienoic acid (HpODE) is found in submacular Bruch's membrane in aged humans and has been reported to generate neovascularization in a rabbit model. Three weeks after a single subretinal injection of 30 μg of HpODE, eyes of Sprague-Dawley rats were harvested. Follow-up fluorescein angiography was done on other animals until 5 weeks postinjection. Histological studies, immunohistochemical staining, and flatmount choroids for CNV measurements were performed. In addition, we used murine neuronal, bovine endothelial, and human ARPE19 cells for testing the in vitro effects of HpODE. CNV developed in 85.7% of HpODE-injected eyes. The neovascular areas were significantly greater in HpODE-injected eyes compared with those in control eyes (P = 0.023). The CNV had maximum dye leakage at 3 weeks, which subsided by the 5th week. Histologically, CNV extended from the choriocapillaris into the subretinal space. ED1-positive macrophages were recruited to the site. In vitro assays demonstrated that only 30 ng/ml HpODE induced cell proliferation and migration of endothelial cells. HpODE-induced CNV was highly reproducible, and its natural course seems to be ideal for evaluating therapeutic modalities. Because HpODE has been isolated from aged humans, the HpODE-induced rat model seems to be a relevant experimental model for CNV in age-related macular degeneration.
UR - http://www.scopus.com/inward/record.url?scp=77953226415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953226415&partnerID=8YFLogxK
U2 - 10.2353/ajpath.2010.090989
DO - 10.2353/ajpath.2010.090989
M3 - Article
C2 - 20395434
AN - SCOPUS:77953226415
SN - 0002-9440
VL - 176
SP - 3085
EP - 3097
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 6
ER -